GreenCTech

AI-based Vision Screening Platform

Health Tech & Life Sciences
Non Active, Aug 2024 ceased to operate
Follow

Company Overview

Snapshot

Founded in December 2015 by Michal Green, GreenCTech operates with 11–50 employees. The company ceased operations in August 2024.

Business overview

GreenCTech develops Eye-N-Joy, an AI-based vision screening platform designed for preventive vision screening in children aged 1 to 17 years. The technology performs comprehensive screenings for healthy eye development, including strabismus and visual acuity, as defined by the AAO. The platform is particularly effective for nonverbal infants and individuals with developmental conditions, enabling visual acuity exams without verbal interaction. Eye-N-Joy's artificial intelligence analyzes data to provide instant diagnoses, ensuring easy, reliable, and accessible vision testing. The company operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Digital Healthcare, focusing on digital medical diagnostics.

Strategic signal

GreenCTech ceased operations in August 2024, indicating a significant and definitive shift in the company's trajectory. This event signals to investors and innovation teams that the venture is no longer active in the market.

Log in to access full profile

Company Intelligence Q&A

What is GreenCTech's primary product?
GreenCTech's primary product is Eye-N-Joy, an AI-based vision screening platform designed for preventive vision screening in children aged 1 to 17 years.
When was GreenCTech founded?
GreenCTech was founded in December 2015.
What is the operational status of GreenCTech?
GreenCTech ceased operations in August 2024.
What markets does GreenCTech target?
GreenCTech targets the healthcare market, specifically focusing on children, babies, and parents, as well as healthcare providers. Its geomarkets include Africa.
What core technologies does GreenCTech utilize?
GreenCTech utilizes Artificial Intelligence and Machine Learning as its core technologies for its vision screening platform.
Log in to access full profile